Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Quoc TP"'
Autor:
Thu HNT; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Thuy DNT; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Vu TP; Kinh 7 Charity Clinic, Kien Giang, Viet Nam., Quoc TP; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Van DN; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Do Manh H; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Thi VD; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Thi DT; National Hospital of Endocrinology, Ha Noi, Viet Nam., Le Ha K; Hanoi Medical University, Ha Noi, Viet Nam., Quy KT; Central Military Hospital 108, Ha Noi, Viet Nam., Trung KN; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam., Le Viet T; Military Hospital 103, Ha Noi, Viet Nam; Vietnam Military Medical University, Ha Noi, Viet Nam. Electronic address: lethangviet@yahoo.co.uk.
Publikováno v:
Transplant immunology [Transpl Immunol] 2024 Nov 23; Vol. 88, pp. 102149. Date of Electronic Publication: 2024 Nov 23.
Autor:
Sekino Y; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan., Sakamoto N; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Goto K; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Honma R; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Shigematsu Y; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan., Quoc TP; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Sentani K; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Oue N; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan., Teishima J; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan., Kawakami F; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karam JA; Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sircar K; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Matsubara A; Department of Urology, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan., Yasui W; Department of Molecular Pathology, Hiroshima University Institute of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. wyasui@hiroshima-u.ac.jp.
Publikováno v:
BMC cancer [BMC Cancer] 2018 Oct 04; Vol. 18 (1), pp. 952. Date of Electronic Publication: 2018 Oct 04.